FDA inspection
Henan Lihua Pharmaceutical Co., Ltd.: FDA inspection ending Feb 13, 2026
FDA inspection 1307966 · Voluntary Action Indicated (VAI) · Anyang
Key facts
| Inspection ID | 1307966 |
|---|---|
| Firm | Henan Lihua Pharmaceutical Co., Ltd. |
| FEI number | 3001164052 |
| Address | Anyang Hi-Tech, Middle Of Huanghe Street; Industry Development Zone |
| City | Anyang |
| Country | China |
| Fiscal year | 2026 |
| Inspection end date | Feb 13, 2026 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data